Highbridge Capital Management »

Zenas Biopharma shares owned by Highbridge Capital Management

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Highbridge Capital Management from 13F filings

Historical chart of Highbridge Capital Management investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Highbridge Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Highbridge Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 20M 0.99

More positions owned by Highbridge Capital Management

Ishares Tr Option Put Option
State Str Spdr S&p 500 Etf T Option Put Option
Ishares Tr Option Put Option
Spdr Series Trust Option Put Option
Electronic Arts Common (EA)
Electronic Arts Option Put Option
Alibaba Group Hldg Bond (Principal)
Super Micro Computer Option Put Option
Ishares Tr Option Call Option
Hologic Common
Ishares Tr Option Put Option
Sarepta Therapeutics Bond (Principal)
Bofa Fin Bond (Principal)
Ironwood Pharmaceuticals Bond (Principal)
Nextera Energy Pref Conv (NEE.PV)

View all positions for Highbridge Capital Management

Top funds holding Zenas Biopharma

Deerfield Management Company
Context Capital Management
Highbridge Capital Management
Jpmorgan Chase & Co
Braidwell
Jane Street
Citadel Advisors
Linden Advisors
Leucadia National Corporation
Capstone Investment Advisors
Monashee Investment Management
D. E. Shaw & Co
Graham Capital Management
Woodline Partners
Calamos Advisors

View all funds holding Zenas Biopharma